Targeting integrins alpha(v)beta(3) and alpha(5)beta(1) with new beta-lactam derivatives
The alpha(v)beta(3) and alpha(5)beta(1) integrins are widely expressed in different cancer types and recognize the tripeptide Arg-Gly-Asp (RGD) motif present in several extracellular matrix proteins. We report here the design, synthesis and biological activity of some new beta-lactam derivatives spe...
Saved in:
Published in | European journal of medicinal chemistry Vol. 83; pp. 284 - 293 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
ISSY-LES-MOULINEAUX
Elsevier
18.08.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The alpha(v)beta(3) and alpha(5)beta(1) integrins are widely expressed in different cancer types and recognize the tripeptide Arg-Gly-Asp (RGD) motif present in several extracellular matrix proteins. We report here the design, synthesis and biological activity of some new beta-lactam derivatives specifically designed to target integrins. The new molecules contain the azetidinone as the only cyclic framework armed with carboxylic acid and amine terminals spaced from 9 to 14 atoms to switch on recognition by integrins. All tested molecules showed a concentration-dependent enhancement in fibronectin-mediated adhesion of K562 and SK-MEL-24 cells; in particular 1, expressed a higher affinity towards alpha(5)beta(1) integrin (EC50 of 12 nM) and 2 was more selective for integrin alpha(v)beta(3) (EC50 of 11 nM). (C) 2014 Elsevier Masson SAS. All rights reserved. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2014.06.041 |